Navigating The EU's Revised Clinical Trial Disclosure Rules
Interim Measures Provide Options For Early Adoption Of The Updated Requirements
The European Medicines Agency is preparing to roll out simplified transparency rules for its Clinical Trials Information System in mid-2024. This article looks at what will change and the impact on the thousands of trials that are already in the system.
